Penetration of lincomycin ('Lincocin') and clindamycin ('Dalacin C') into the synovial cavity in rheumatoid arthritis.
D000284:Administration, Oral; D000368:Aged; D001170:Arthritis, Infectious / Q000188:drug therapy; D001172:Arthritis, Rheumatoid / Q000378:metabolism*; D002981:Clindamycin / Q000008:administration & dosage / Q000032:analysis / Q000097:blood / Q000378:metabolism*; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D008034:Lincomycin / Q000008:administration & dosage / Q000032:analysis / Q000097:blood / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D013203:Staphylococcal Infections / Q000188:drug therapy; D013582:Synovial Fluid / Q000032:analysis / Q000378:metabolism*; D013997:Time Factors
D002981:Clindamycin; D008034:Lincomycin